De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

evertex fabrinology Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Anthony Yeh

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	4.8yrs

Recente managementupdates

Recent updates

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02

CEO

Anthony Yeh

no data

Tenure

Poliang Yeh, also known as Anthony, is President of evertex fabrinology limited.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Ye Qingze	Director	no data	geen gegevens	2.21% NT$ 41.7m
Xu Rongxin	Director	no data	geen gegevens	2.89% NT$ 54.5m
Ye Guohui	Director	no data	geen gegevens	0.30% NT$ 5.7m
Yang Yaozhou	Director	no data	geen gegevens	3.71% NT$ 69.9m
Ye Zhiming	Director	4.8yrs	geen gegevens	geen gegevens
Funan Zhou	Independent Director	no data	geen gegevens	geen gegevens
Binghuang Lin	Independent Director	no data	geen gegevens	geen gegevens
Bai Liang Ye	Director	4.8yrs	geen gegevens	4.68% NT$ 88.1m
Wu Zhong Liao	Independent Director	4.8yrs	geen gegevens	geen gegevens
Fa Yeh Chuan	Chairman of the Board	no data	geen gegevens	geen gegevens

4.8yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 1470 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

evertex fabrinology Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

evertex fabrinology limited, Annual General Meeting, Jun 25, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: NT$0.27 (vs NT$0.10 in 2Q 2023)

evertex fabrinology limited to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$0.58 per share

First quarter 2024 earnings released: EPS: NT$0.36 (vs NT$0.41 in 1Q 2023)

Dividend increased to NT$0.58

Evertex Fabrinology Ltd. Announces Cash Dividend, Payable on August 16, 2024

evertex fabrinology limited to Report Q1, 2024 Results on May 10, 2024

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: NT$0.58 (vs NT$0.38 in FY 2022)

evertex fabrinology limited, Annual General Meeting, Jun 25, 2024

Third quarter 2023 earnings released: EPS: NT$0.06 (vs NT$0.15 in 3Q 2022)

Second quarter 2023 earnings released: EPS: NT$0.10 (vs NT$0.071 loss in 2Q 2022)

Upcoming dividend of NT$0.45 per share at 2.3% yield

Full year 2022 earnings released: EPS: NT$0.38 (vs NT$0.76 in FY 2021)

Less than half of directors are independent

Second quarter 2022 earnings released: NT$0.07 loss per share (vs NT$0.34 profit in 2Q 2021)

Upcoming dividend of NT$0.80 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: NT$0.31 (vs NT$0.076 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: NT$0.76 (vs NT$0.41 in FY 2020)

Third quarter 2021 earnings released: EPS NT$0.15 (vs NT$0.11 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.11 loss in 2Q 2020)

Upcoming dividend of NT$0.42 per share

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Full year 2020 earnings released: EPS NT$0.41 (vs NT$0.89 in FY 2019)

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

New 90-day low: NT$17.55

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Third quarter 2020 earnings released: EPS NT$0.11

New 90-day low: NT$17.50

New 90-day low - NT$17.75

First half earnings released

Upcoming Dividend of NT$0.80 Per Share

CEO

Tenure

Bestuursleden

Gemiddelde duur